Market Overview

Pharmacyclics Rumor: How Some Wall Street Analysts Are Reacting

Related PCYC
Goldman Sachs Talks Pfizer's Acquisition Deal Of Medivation
JMP Sees A 'Negative Market Tone' In Biotechnology
Related ONTY
Oncothyreon Presented Novel Checkpoint Kinase 1 Inhibitors at AACR Meeting
13D Filing From Biotechnology Value Fund On Oncothyreon Reveals 19.8% Stake

Oncothyreon Inc (USA) (NASDAQ: ONTY) is up on Wednesday afternoon after a rumor of a possible move on Pharmacyclics, Inc. (NASDAQ: PCYC) hit the wires. Pharmacyclics is up nearly 17 percent.

Adam Feuerstein (@adamfeuerstein), of TheStreet, tweeted a note on the news from Bernstein's trading desk.

Latest Ratings for PCYC

Mar 2015Leerink SwannDowngradesOutperformMarket Perform
Mar 2015NomuraDowngradesBuyNeutral
Mar 2015Wells FargoDowngradesOutperformMarket Perform

View More Analyst Ratings for PCYC
View the Latest Analyst Ratings

Posted-In: Analyst Color Biotech Long Ideas News Rumors M&A Analyst Ratings Movers


Related Articles (ONTY + PCYC)

View Comments and Join the Discussion!